Cyprotex to Offer New Long-Term Toxicity Testing Service Using…

InSphero AG, experts in three dimensional microtissue research, and Cyprotex PLC (LSE: CRX), the specialist preclinical contract research organisation (CRO), announce a joint service offering which...

(PRWeb September 17, 2012)

Read the full story at

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: